세계의 소아 헬스케어 시장 예측(-2030년) : 제품 유형별, 질병 유형별, 서비스 유형별, 치료 유형별, 최종사용자별, 지역별 분석

According to Stratistics MRC, the Global Pediatric Healthcare Market is accounted for $14.4 billion in 2024 and is expected to reach $20.9 billion by 2030 growing at a CAGR of 6.4% during the forecast period. Pediatric healthcare is the medical care and treatment provided to children and adolescents, from infancy through adolescence. It encompasses a wide range of services, including preventive health care, diagnosis and treatment of illnesses, management of chronic conditions, and developmental and behavioral assessments. The goal is to ensure the optimal physical, emotional, and mental health of young patients. Pediatric healthcare professionals are trained to address the unique needs of children at different stages of development.

According to Observer Research Foundation data published in December 2021, India has nearly 200 million undernourished people. According to the Genworth Cost of Care Survey, skilled nursing services in private homes cost an average of $290 per day, while semi-private homes cost an average of $255.

Market Dynamics:

Driver:

Increasing awareness and parental involvement

Increasing awareness and parental involvement in the market have led to significant improvements in child health outcomes. Parents are now more informed about preventive care, vaccinations, and the importance of early detection of illnesses. This proactive approach has increased demand for pediatric services, wellness programs, and specialized care. Additionally, parents are actively engaging in decision-making regarding their child's healthcare, seeking quality medical advice and holistic care options.

Restraint:

Shortage of pediatric specialists

The shortage of pediatric specialists negatively impacts the market by limiting access to specialized care for children. This scarcity leads to longer wait times, delays in diagnosis and increased pressure on general pediatricians to manage complex cases. Consequently, children may experience suboptimal care and worsened health outcomes. The shortage also burdens existing specialists, leading to burnout and decreased quality of care. Overall, it hinders the ability to provide comprehensive and timely medical attention to young patients.

Opportunity:

Expanding healthcare infrastructure

Expanding healthcare infrastructure can help address the shortage of pediatric specialists in the market. By building more hospitals, clinics, and training facilities, healthcare systems can increase the capacity to educate and employ pediatric specialists. This expansion can also improve access to advanced diagnostic tools and specialized services in underserved areas. Additionally, telemedicine and digital health platforms can extend the reach of existing specialists, ensuring more children receive the necessary care.

Threat:

High cost of pediatric care

The high cost of pediatric care negatively impacts the market by creating barriers to access for many families. Rising costs for consultations, treatments, and specialized services can lead to financial strain, causing some parents to delay or forego necessary care for their children. This can result in worsening health conditions and increased emergency visits, which are more costly in the long run. The financial burden may also deter parents from seeking preventive care, ultimately affecting children's overall health and well-being.

Covid-19 Impact:

COVID-19 significantly impacted the pediatric healthcare market, causing disruptions in routine care, vaccinations, and elective procedures. Fear of exposure led to decreased hospital visits, delaying critical care and preventive services. Additionally, the pandemic strained healthcare resources, diverting attention and funding away from pediatric services. The overall impact includes worsened health outcomes for children and increased stress on healthcare providers and systems.

The chronic diseases segment is expected to be the largest during the forecast period

The chronic diseases is expected to be the largest during the forecast period. The rise in chronic illnesses strains healthcare resources and necessitates a multidisciplinary approach to treatment. Early diagnosis, continuous monitoring, and coordinated care are crucial for managing these conditions effectively. The prevalence of chronic diseases also highlights the need for comprehensive healthcare policies and improved access to pediatric specialists and support services.

The behavioral therapy segment is expected to have the highest CAGR during the forecast period

The behavioral therapy segment is expected to have the highest CAGR during the forecast period. The growing recognition of mental health's importance has increased demand for these services. Behavioral therapy helps children develop coping skills, improve social interactions, and manage behaviors effectively. As awareness and acceptance of mental health issues rise, the market for pediatric behavioral therapy continues to expand, offering tailored support for young patients.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by advanced medical technologies, high-quality healthcare infrastructure, and strong insurance coverage. The region has a well-established network of pediatric specialists and healthcare facilities, offering comprehensive services from preventive care to specialized treatments. Rising awareness of child health issues, coupled with increasing investment in pediatric research and innovation, further fuels market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to expanding healthcare infrastructure. Governments and private sectors are investing heavily in healthcare facilities, including children's hospitals and clinics, to address the needs of young patients more effectively. Enhanced access to healthcare services, including vaccinations and routine check-ups, is improving overall child health outcomes. Additionally, the rise of telemedicine and digital health solutions is making pediatric care more accessible, particularly in remote areas.

Key players in the market

Some of the key players in Pediatric Healthcare market include Johnson & Johnson, Pfizer Inc., Roche Holding AG, Novartis International AG, Merck & Co., Inc., Sanofi, GlaxoSmithKline plc, AbbVie Inc., Eli Lilly and Company, AstraZeneca plc, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Bristol-Myers Squibb Company, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim GmbH, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd. and Mylan N.V.

Key Developments:

In April 2024, Novartis announced that the U.S. Food and Drug Administration (FDA) approved Lutathera(R) for the treatment of pediatric patients 12 years and older with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut NETs.

In April 2024, Pfizer Inc announced positive top-line immunogenicity and safety data from the ongoing pivotal Phase 3 clinical trial (NCT05842967) MONeT (RSV IMmunizatiON Study for AdulTs at Higher Risk of Severe Illness),evaluating a single dose of ABRYSVO versus placebo in adults 18 to 59 years of age

Product Types Covered:

• Diagnostic Devices
• Monitoring Devices
• Laboratory Equipment
• Infusion Pumps
• Pediatric Braces
• Other Product Types

Disease Types Covered:

• Infectious Diseases
• Chronic Diseases
• Hematological Disorders
• Genetic Disorders
• Respiratory Disorders
• Gastrointestinal Disorders
• Cardiovascular Disorders
• Other Disease Types

Service Types Covered:

• Inpatient Care
• Outpatient Care
• Emergency Services
• Rehabilitation Services
• Home Healthcare
• Palliative and Hospice Care

Treatment Types Covered:

• Medication and Therapeutics
• Surgery and Medical Procedures
• Radiation Therapy
• Physical and Occupational Therapy
• Behavioral Therapy
• Dietary and Nutritional Therapy
• Gene Therapy

End Users Covered:

• Hospitals
• Pediatric Clinics
• Home Care Settings
• Research Institutes
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Pediatric Healthcare Market, By Product Type

• 5.1 Introduction
• 5.2 Diagnostic Devices
• 5.3 Monitoring Devices
• 5.4 Laboratory Equipment
• 5.5 Infusion Pumps
• 5.6 Pediatric Braces
• 5.7 Other Product Types

6 Global Pediatric Healthcare Market, By Disease Type

• 6.1 Introduction
• 6.2 Infectious Diseases
• 6.3 Chronic Diseases
• 6.4 Hematological Disorders
• 6.5 Genetic Disorders
• 6.6 Respiratory Disorders
• 6.7 Gastrointestinal Disorders
• 6.8 Cardiovascular Disorders
• 6.9 Other Disease Types

7 Global Pediatric Healthcare Market, By Service Type

• 7.1 Introduction
• 7.2 Inpatient Care
• 7.3 Outpatient Care
• 7.4 Emergency Services
• 7.5 Rehabilitation Services
• 7.6 Home Healthcare
• 7.7 Palliative and Hospice Care

8 Global Pediatric Healthcare Market, By Treatment Type

• 8.1 Introduction
• 8.2 Medication and Therapeutics
• 8.3 Surgery and Medical Procedures
• 8.4 Radiation Therapy
• 8.5 Physical and Occupational Therapy
• 8.6 Behavioral Therapy
• 8.7 Dietary and Nutritional Therapy
• 8.8 Gene Therapy

9 Global Pediatric Healthcare Market, By End User

• 9.1 Introduction
• 9.2 Hospitals
• 9.3 Pediatric Clinics
• 9.4 Home Care Settings
• 9.5 Research Institutes
• 9.6 Other End Users

10 Global Pediatric Healthcare Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Johnson & Johnson
• 12.2 Pfizer Inc.
• 12.3 Roche Holding AG
• 12.4 Novartis International AG
• 12.5 Merck & Co., Inc.
• 12.6 Sanofi
• 12.7 GlaxoSmithKline plc
• 12.8 AbbVie Inc.
• 12.9 Eli Lilly and Company
• 12.10 AstraZeneca plc
• 12.11 Astellas Pharma Inc.
• 12.12 Takeda Pharmaceutical Company Limited
• 12.13 Novo Nordisk A/S
• 12.14 Bristol-Myers Squibb Company
• 12.15 Amgen Inc.
• 12.16 Gilead Sciences, Inc.
• 12.17 Boehringer Ingelheim GmbH
• 12.18 Hikma Pharmaceuticals PLC
• 12.19 Teva Pharmaceutical Industries Ltd.
• 12.20 Mylan N.V.